Skip to Content
  • Previous Rank147
  • Revenues ($M)$20,776.00
  • Revenue Percent Change6.9%
  • Profits ($M)$1,007.00
  • Profits Percent Change-77.4%
  • Assets ($M)$33,551.00
  • Employees23,700
  • Market Value — as of March 29, 2018 ($M)$103,415.30

The biopharmaceutical company manufactures medicines for Alzheimer’s, dementia, pyschiatric disorders, cardiovascular, diabetes, oncology, and hepatitis.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

Giovanni Caforio
CEO Title
Chairman & Chief Executive Officer
Health Care
HQ Location
New York City
Years on Fortune 500 List24

Bristol-Myers Squibb Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$20,776.006.9%
Profits ($M)$1,007.00-77.4%
Assets ($M)$33,551.00-
Total Stockholder Equity ($M)$11,741.00-
Market Value — as of March 29, 2018 ($M)$103,415.30-

Profit Ratios

Profit as % of Revenues4.8%
Profits as % of Assets3%
Profits as % of Stockholder Equity8.6%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)0.61
EPS % Change (from 2016)-77%
EPS % Change (5 year annual rate)-12.1%
EPS % Change (10 year annual rate)-5.6%

Total Return

Total Return to Investors (2017)7.8%
Total Return to Investors (5 year, annualized)16.6%
Total Return to Investors (10 year, annualized)13%